1. (1) Cannabis product labeling shall contain the following information:

   1. (a) the medicinal dosage form identified on the product face along with the words "THC or Cannabis Infused":

      1. (i) "gummies" may be used instead of "gelatinous cube";
      2. (ii) "tincture" may be used instead of "sublingual preparation" or "liquid suspension";
      3. (iii) a descriptive product name, that is not appealing to children, recreational, or contain adjectives;
   2. (b) the name and license number of the cannabis processing facility;
   3. (c) directions for consumers to contact the department with product complaints by going to medicalcannabis.utah.gov/production;
   4. (d) for products containing THC, a warning symbol provided by the department that contrasts conspicuously with the background; and
   5. (e) the amount of total THC contained in the package, in milligrams.
2. (2) A cannabis processing facility may include a QR code on the cannabis product labeling that links to a COA from a licensed independent cannabis testing laboratory. The QR code may not link to any other information.

3. (3) Any information appearing on the cannabis product labeling shall be:

   1. (a) displayed in any legible font, that is not a script or decorative font, provided that the lowercase letter "o" is at least one-sixteenth inch in height;
   2. (b) displayed in a color that contrasts conspicuously with its background; and
   3. (c) displayed in English, although a licensee may also choose to display required information in additional languages.
4. (4) A cannabis processing facility shall place a cannabis fact panel on a cannabis product before the sale of the cannabis product to a medical cannabis pharmacy.
5. (5) The cannabis fact panel shall be printed in black and white.
6. (6) The cannabis fact panel shall be securely affixed to the package.

7. (7) The cannabis fact panel for cannabis plant product shall include the following information, from top to bottom, in the order as listed:

   1. (a) the name of the cannabis cultivation facility, identified as the cultivator;
   2. (b) the lot number;
   3. (c) the date of harvest;
   4. (d) the date of final testing;
   5. (e) the batch number;
   6. (f) the date on which the product was packaged;
   7. (g) the quantity of any cannabinoid listed as present on the COA that is greater than 1% of total cannabinoids;

   8. (h) the expiration date; and

      1. (i) the net weight displayed in grams.
8. (8) THC potency levels for cannabis flower shall be listed as total THC in milligrams per gram.

9. (9) The cannabis fact panel for a cannabis derivative product shall include the following information, from top to bottom, in the order listed:

   1. (a) the batch number;
   2. (b) the date of the final testing;
   3. (c) the date on which the product was packaged;
   4. (d) for products intended to be ingested, the amount of total THC and any advertised cannabinoid in milligrams per serving;
   5. (e) the quantity of any cannabinoid listed as present on the COA that is greater than 1% of total cannabinoids;
   6. (f) the expiration date;
   7. (g) the total amount of THC measured in milligrams per gram;

   8. (h) a list of each ingredient and each major food allergen as identified in 21 U.S.C. 343;

      1. (i) the identity of any artificially derived cannabinoid present in the product;
   9. (j) the net weight of the product displayed in grams or milliliters and the number of pieces, if applicable; and
   10. (k) a disclosure of the type of extraction process used and any solvent, gas, or other chemical used in the extraction process.
10. (10) A cannabis processing facility may include a QR code affixed to the product that is scannable for inventory control at the pharmacy. The QR code may not link to any other information.
11. (11) The label of a cannabis derivative product may include a flavor name if it is not candy-like or a name that appeals to children.
12. (12) The label of a cannabis product that contains an artificially derived cannabinoid shall clearly display the following text: "This product contains artificially derived cannabinoids."
13. (13) Any terpene listed on a cannabis product package shall be verified as present by a licensed independent cannabis testing laboratory and have its quantity listed on the fact panel.

14. (14) A cannabis processing facility may include a logo and product brand name on the cannabis product face that is exempt from the requirements of Subsection R66-2-13(5) and that:

    1. (a) does not obscure the information required on the label; and

    2. (b) does not include:

       1. (i) terms, slang, phrasing, or verbiage associated with the recreational use of cannabis;
       2. (ii) any image bearing resemblance to a cartoon character or fictional character whose target audience is children or minors;
       3. (iii) content, symbol, or imagery that appeals to children;
       4. (iv) imagery featuring a person using the product in any way;
       5. (v) any recreationally oriented subject; or
       6. (vi) any statement, design, or representation, picture, or illustration that is obscene, sexual, or criminal.

15. (15)(a) No other information, illustration, or depiction with the exception of directions for use or an item required by state law shall appear on the labeling.

    1. (b) Any warnings required in Chapter 4-41a may be added to the label of any product.
16. (16) Shapes on cannabis product packaging or labeling may not resemble the product or real-world items.
17. (17) Labeling may not contain medical claims.
18. (18) Cannabis product packaging, logos, and brand names shall be pre-approved by the department.
19. (19) The department reserves the right to deny any label, logo, or brand name if the department reasonably believes it is in conflict with Chapter 4-41a or this section.

KEY: cannabis processing, cannabis production establishment, violations, targeted marketing, qualifications, and requirements

Date of Last Change: January 7, 2026

Authorizing, and Implemented or Interpreted Law: 4-41a-103(5); 4-41a-404(3); 4-41a-701(3); 4-41a-302(3)(b)(ii); 4-2-103(1)(i); 4-41a-405(2)(b)(iv); 4-41a-801(1)